A so-called "diabetes belt" reflecting a far higher prevalence of diabetes than in the rest of the US exists.
A so-called "diabetes belt" reflecting a far higher prevalence of diabetes than in the rest of the US exists and includes the entire state of Mississippi; much of Alabama, Georgia, Kentucky, Louisiana, South Carolina, Tennessee, and West Virginia; parts of Arkansas, North Carolina, and Virginia; and bits of Florida, Ohio, Pennsylvania, and Texas.
Data from the 2007 and 2008 Behavioral Risk Factor Surveillance System was combined with county-level diagnosed diabetes prevalence estimates to identify 644 counties in 15 mostly southern states with an estimated prevalence of diagnosed diabetes of 11.0% or higher. Prevalence of diabetes within the belt was 11.7% (95% CI, 11.4%-12.0%), while the prevalence in the rest of the country was 8.5% (95% CI, 8.3%-8.6%).
People in the belt were more likely to be non-Hispanic African American (23.8% vs 8.6%), lead a sedentary lifestyle (30.6% vs 24.8%), and be obese (32.9% vs 26.1%) than people in the rest of the US. They also were less likely to have a college degree (24.1% vs 34.3%). Thirty percent of the excess risk was associated with modifiable risk factors and 37% with nonmodifiable factors.
The authors of the study note that much of the area in the diabetes belt was formerly agricultural. People there may have continued to consume high-calorie diets appropriate for agricultural labor after the need no longer existed.
Barker LE, Kirtland KA, Gregg EW, Geiss LS, Thompson TJ. Geographic distribution of diagnosed diabetes in the U.S. A diabetes belt. Am J Prev Med. 2011;40(4):434-439.
Single iron infusion in late pregnancy significantly reduces anemia risk
January 22nd 2025A recent study found that a single dose of intravenous iron in the third trimester is superior to oral iron in reducing anemia rates in pregnant women, ensuring better outcomes for mother and baby.
Read More
FDA grants 510(k) clearance to cobas liat STI multiplex assay panels
Published: January 22nd 2025 | Updated: January 22nd 2025The new panels, leveraging rapid polymerase chain reaction technology, allow point of care sexually transmitted infection diagnosis in 20 minutes, enhancing targeted treatment and reducing follow-up losses.
Read More